CN1308678A - Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use - Google Patents
Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use Download PDFInfo
- Publication number
- CN1308678A CN1308678A CN99805473A CN99805473A CN1308678A CN 1308678 A CN1308678 A CN 1308678A CN 99805473 A CN99805473 A CN 99805473A CN 99805473 A CN99805473 A CN 99805473A CN 1308678 A CN1308678 A CN 1308678A
- Authority
- CN
- China
- Prior art keywords
- seq
- nucleic acid
- plant
- gene
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 114
- 238000000034 method Methods 0.000 title claims abstract description 73
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 61
- 235000009566 rice Nutrition 0.000 title claims abstract description 61
- 241001344131 Magnaporthe grisea Species 0.000 title claims abstract description 55
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 10
- 244000052769 pathogen Species 0.000 title abstract description 6
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 64
- 241000196324 Embryophyta Species 0.000 claims description 83
- 108020004707 nucleic acids Proteins 0.000 claims description 55
- 102000039446 nucleic acids Human genes 0.000 claims description 55
- 150000007523 nucleic acids Chemical class 0.000 claims description 55
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 43
- 229920001184 polypeptide Polymers 0.000 claims description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 38
- 210000004027 cell Anatomy 0.000 claims description 33
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 claims description 28
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 claims description 28
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 claims description 28
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 claims description 28
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 claims description 28
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 claims description 28
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 claims description 28
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 claims description 28
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 claims description 28
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 claims description 28
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 claims description 28
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 claims description 28
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 claims description 28
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 claims description 28
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 claims description 28
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 claims description 28
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 claims description 28
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 claims description 28
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 claims description 28
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 claims description 28
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 claims description 28
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 claims description 28
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 claims description 28
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 claims description 28
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 claims description 28
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 claims description 28
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 claims description 28
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 claims description 28
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 claims description 28
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 claims description 28
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 claims description 28
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 claims description 28
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 claims description 28
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 claims description 28
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 claims description 28
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 claims description 28
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 claims description 28
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 claims description 28
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 claims description 28
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 claims description 28
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 claims description 28
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 claims description 28
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 claims description 28
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 claims description 28
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 claims description 28
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 claims description 28
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 claims description 28
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 claims description 28
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 claims description 28
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 claims description 28
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 claims description 28
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 claims description 28
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 claims description 28
- 230000014509 gene expression Effects 0.000 claims description 26
- 238000009396 hybridization Methods 0.000 claims description 25
- 230000001580 bacterial effect Effects 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 235000018102 proteins Nutrition 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 17
- 231100000956 nontoxicity Toxicity 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- 230000035772 mutation Effects 0.000 claims description 9
- 230000000295 complement effect Effects 0.000 claims description 8
- 230000009261 transgenic effect Effects 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 6
- 230000036039 immunity Effects 0.000 claims description 6
- 244000000010 microbial pathogen Species 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 108020004511 Recombinant DNA Proteins 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 229940084434 fungoid Drugs 0.000 claims 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 230000000680 avirulence Effects 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 description 37
- 201000010099 disease Diseases 0.000 description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 31
- 241001232809 Chorista Species 0.000 description 22
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 20
- 150000001413 amino acids Chemical class 0.000 description 20
- 108700026215 vpr Genes Proteins 0.000 description 17
- 101150090155 R gene Proteins 0.000 description 16
- 239000012634 fragment Substances 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 12
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 11
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 11
- 102100024407 Jouberin Human genes 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 9
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 9
- 238000011081 inoculation Methods 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 8
- 241000233866 Fungi Species 0.000 description 8
- 230000003993 interaction Effects 0.000 description 7
- 230000010363 phase shift Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000010367 cloning Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000004927 clay Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- -1 methane amide Chemical class 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 208000035240 Disease Resistance Diseases 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 102220023257 rs387907546 Human genes 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 101710197985 Probable protein Rev Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 230000009184 walking Effects 0.000 description 3
- QKHXKQJMUZVCJM-QRPNPIFTSA-N (2s)-2-amino-3-phenylpropanoic acid;azane Chemical compound N.OC(=O)[C@@H](N)CC1=CC=CC=C1 QKHXKQJMUZVCJM-QRPNPIFTSA-N 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 2
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 2
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 2
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 2
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 2
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 2
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 2
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 2
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 2
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 2
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 2
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 2
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 2
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 2
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 2
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 2
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 2
- 101710087110 ORF6 protein Proteins 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 2
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 2
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 2
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 2
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 2
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 2
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 2
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 2
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000000280 phytoalexin Substances 0.000 description 2
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010002961 Aplasia Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 1
- 101000977023 Azospirillum brasilense Uncharacterized 17.8 kDa protein in nodG 5'region Proteins 0.000 description 1
- 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 1
- 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 1
- 101000961984 Bacillus thuringiensis Uncharacterized 30.3 kDa protein Proteins 0.000 description 1
- 101150088200 CF-9 gene Proteins 0.000 description 1
- 101100008046 Caenorhabditis elegans cut-2 gene Proteins 0.000 description 1
- 101100008047 Caenorhabditis elegans cut-3 gene Proteins 0.000 description 1
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 1
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- RDFLLVCQYHQOBU-GPGGJFNDSA-O Cyanin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@H](CO)O1)c1c(-c2cc(O)c(O)cc2)[o+]c2c(c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)cc(O)c2)c1 RDFLLVCQYHQOBU-GPGGJFNDSA-O 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 235000017896 Digitaria Nutrition 0.000 description 1
- 241001303487 Digitaria <clam> Species 0.000 description 1
- 101000644901 Drosophila melanogaster Putative 115 kDa protein in type-1 retrotransposable element R1DM Proteins 0.000 description 1
- 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 1
- 101000747702 Enterobacteria phage N4 Uncharacterized protein Gp2 Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 1
- 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 101000758599 Escherichia coli Uncharacterized 14.7 kDa protein Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 108010000916 Fimbriae Proteins Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 101000768930 Lactococcus lactis subsp. cremoris Uncharacterized protein in pepC 5'region Proteins 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 1
- 101000976302 Leptospira interrogans Uncharacterized protein in sph 3'region Proteins 0.000 description 1
- 101000778886 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) Uncharacterized protein LA_2151 Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- HDVCHBLHEICPPP-UHFFFAOYSA-N O=P(=O)C1=CC=NC(P(=O)=O)=C1P(=O)=O Chemical class O=P(=O)C1=CC=NC(P(=O)=O)=C1P(=O)=O HDVCHBLHEICPPP-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150101414 PRP1 gene Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 1
- 101100368710 Rattus norvegicus Tacstd2 gene Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 1
- 101001121571 Rice tungro bacilliform virus (isolate Philippines) Protein P2 Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100342406 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PRS1 gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 1
- 101000818098 Spirochaeta aurantia Uncharacterized protein in trpE 3'region Proteins 0.000 description 1
- 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 1
- 101001026590 Streptomyces cinnamonensis Putative polyketide beta-ketoacyl synthase 2 Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 1
- 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 1
- 101000750896 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized protein Synpcc7942_2318 Proteins 0.000 description 1
- 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 101000916321 Xenopus laevis Transposon TX1 uncharacterized 149 kDa protein Proteins 0.000 description 1
- 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 1
- 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 1
- 101000760088 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 20.9 kDa protein Proteins 0.000 description 1
- 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000003967 crop rotation Methods 0.000 description 1
- RDFLLVCQYHQOBU-ZOTFFYTFSA-O cyanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=C(O)C(O)=CC=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 RDFLLVCQYHQOBU-ZOTFFYTFSA-O 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical class CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- CLVOYFRAZKMSPF-UHFFFAOYSA-N n,n-dibutyl-4-chlorobenzenesulfonamide Chemical compound CCCCN(CCCC)S(=O)(=O)C1=CC=C(Cl)C=C1 CLVOYFRAZKMSPF-UHFFFAOYSA-N 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000019254 respiratory burst Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 102220023258 rs387907548 Human genes 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000013606 secretion vector Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Abstract
This invention provides a novel avirulence gene from the rice blast pathogen, Magnaporthe grisea. The gene, AVR1-CO39, confers cultivar-specific avirulence to strains of M. grisea that carry the gene. Also disclosed are methods of using the gene and its encoded products for improving resistance of rice to the rice blast pathogen.
Description
Regulation according to 35 U.S.C. § 202 (C), should think that United States Government has the part right to the present invention, study sources of funds of the present invention in USDA, fund 58-3655-3-107 and 58-3655-4-140, and National Institutes of Health, fund GM33716-08S1.
Invention field
The present invention relates to the plant disease-resistant field.Especially, the invention provides the non-toxic gene that derives from rice blast cause of disease i(magnaporthe grisea) (Magnaporthe grisea) of a novelty and use this gene and its coded product to improve the method for paddy rice to the rice blast pathogen resistance.
Background of invention
Paddy rice is the main food of about 2/3rds world population.Plant and consumption in developing country more than 90% paddy rice in the whole world.By the rice blast that the fungi i(magnaporthe grisea) causes, threaten global rice crop.In infected cultivated area, this disease causes the production loss of 10-30%.Rice blast has become the serious day by day problem of paddy fields of southern US.At present, it also becomes the subject matter of California paddy fields.
" gene pairs gene " hypothesis has been explained the relation of very special disease resistance/susceptibility, and this relation often is present between the Cultivar of phytopathy original seed and its host species.Have been found that this hypothesis can be used for the interaction of many host-cause of diseases, comprises the interaction of rice blast fungi i(magnaporthe grisea) and its host paddy rice.Can understand and handle this host and the cause of disease mutual relationship has huge use value, because i(magnaporthe grisea) just can promptly overcome the new disease resistance of paddy rice soon after they disseminate.And the i(magnaporthe grisea) that exists as complicated kind has many sterile and have inferior special a group of different host ranges.Mutual relationship on these different inferior special groups are evolved receives plant breeder's very big concern, because some alternate hosts often are grown near the paddy rice or with the paddy rice crop rotation, and the i(magnaporthe grisea) chorista that infects these alternate hosts also can infect paddy rice sometimes.
Gene pairs gene resistance (being also referred to as super quick resistance (HR) or the special resistance of kind) depends on by this plant invading the activation in the cause of disease specific recognition process.Identified many one plant genes, these Gene Handling the resistance of gene pairs gene.These genes are called as resistance (R) gene.The function of specific R gene depends on the genotype of cause of disease.If its expression causes cause of disease and produces a kind of signal that can stimulate the strong defence of the vegetalitas that has corresponding R gene to reply that this gene just is called the Avr gene so.When in Avr gene in the cause of disease or the plant during corresponding R gene deletion, do not observe this replying.It should be noted that single plant has many R genes, and single cause of disease have many Avr genes.Yet, have only when the Avr gene mates in host-cause of disease interacts with its special R gene, just produce the intensive resistance.In this example, resistance appears in general activation of replying owing to HR, wherein, further invades the living plant tissue in order to prevent cause of disease, and the cell in the next-door neighbour infected area can carry out procedural necrosis.Other features that resistance is replied also comprise the synthetic of antimicrobial metabolite or inhibition cause of disease enzyme, thicken cell walls in the infected area, and the formation of inducing the signal transduction pathway that causes plant whole body acquired resistance (SAR).
The molecular basis of host in i(magnaporthe grisea)-Cultivar specificity and cause of disease variability, adopt identification method, graphing method and in some instances, the method for the special Avr gene of clone begins to illustrate from i(magnaporthe grisea) pathogen separation body.For example, as the non-toxic gene AVR2-YAMO (Cultivar specificity) and PWL2 (the host specificity) (Valent﹠amp of classics; Chumley, rice blast) (this book is by R.Zeigler, S.A.Leong, P.Teng writes), 3.113-3.134 page or leaf, Wallingford:CABInternational, 1994), work by the infection that prevents special Cultivar or host.A kind of 223 amino acid whose albumen that have homology with proteolytic enzyme of AVR2-YAMO coding, and a kind of 145 amino acid whose albumen that are rich in glycine of PWL2 coding.According to these Argine Monohydrochloride sequences of prediction, 2 kinds of albumen all can be secreted.
The phenomenon of AVR2-YAMO and PWL2 homology extensively distributes in paddy rice and other infect the i(magnaporthe grisea) choristas of weeds, and the i(magnaporthe grisea) chorista of therefore confirming not infect paddy rice still carries host or the specific gene of Cultivar at paddy rice.In some cases, shown that the homology of AVR2-YAMO and PWL2 has function, and shown host identical or Cultivar specificity with AVR2-YAMO or PWL2.
Potential the example of the Avr gene of using value is arranged is Cultivar specific gene AVRl-CO39 as another, it determines the nontoxicity at rice cultivar CO39, this gene is identified (Valent et al., Genetics 127:87-101,1991) (Smith﹠amp and on the position of the i(magnaporthe grisea) karyomit(e) 1 of mapping; Leong, Theor.Appl.Gent.88:901-908,1994).A part that contains the AVRl-CO39 gene on the karyomit(e) 1, be separated and be cloned into (Leong et al. in the cosmid vector, the 846-852 page or leaf, Rice Genetice III, Proceeding of the Third Annual RiceGenetics Svmposium, G.S.Khush writes, Island Harbor Press, Manila, 1996); But, this gene itself is not identified and is determined certain characteristic up to now.
From the clone Cultivar of i(magnaporthe grisea) and the validity of host specificity gene, and, provide the useful tool of this area operation and enhancing pathogen resistance finally from the corresponding R gene of paddy rice.Correspondingly, an object of the present invention is to provide a kind of i(magnaporthe grisea) Cultivar specific gene AVR1-CO39 of new clone and its functional analogue of carrying out above-mentioned application.
The present invention's general introduction
According to an aspect of the present invention, provide a kind of isolating nucleic acid, AVR1-CO39, it is from i(magnaporthe grisea) and give rice cultivar CO39 to containing the special nontoxicity of Mycophyta cause of disease of this nucleic acid.Described nucleic acid preferably comprises part or all of Sequence Identification number 1, or can with part or all of Sequence Identification number 1 or its complement hybridization.
According to a further aspect in the invention, provide a kind of by part or all of claim 1 an isolating nucleic acid encoded polypeptide.Preferably, these polypeptide be selected from respectively with Sequence Identification numbers 2,3,4,5,6,7 and 8 accordingly by ORFS 1,2,3,4,5,6 and 7 encoded polypeptides, most preferably by the ORF3 encoded polypeptides.
According to a further aspect in the invention, provide a kind of genetically modified growing nonparasitically upon another plant in the bacterium of plant, the AVR1-CO39 gene of this bacterial expression part, described gene are given rice cultivar CO39 the special nontoxicity at the microorganism of expressing this gene effectively.Preferably, genetically modified growing nonparasitically upon another plant in ORF3 or the functional equivalent of the bacterial expression serial ID No.1 of plant.
According to a further aspect in the invention, provide a kind of method that strengthens rice cultivar CO39 plant at the resistance scope of pathogenic micro-organism.This method comprises with a kind of grows nonparasitically upon another plant in the bacterial treatment plant of plant, the AVR1-CO39 gene of this bacterial expression part, and this part can stimulate the special R expression of gene of CO39 effectively in plant materials.
According to a further aspect in the invention, provide second kind of method that strengthens rice cultivar CO39 plant at the resistance scope of pathogenic micro-organism.This method comprises with a kind of protein extract handles plant, and this extract comprises by expressing the polypeptide that AVR1-CO39 produced, and used amount can be effectively in the special R expression of gene of plant materials internal stimulus CO39.
These and other feature and advantage of the present invention will be described in the content of following proposition and embodiment in more detail.The present invention describes in detail
I. definition
The various terms relevant with biological molecule of the present invention above using, also use in whole specification sheets and claim.Term " substantially the same ", " percentage similarity " and " percentage consistence " be the specific definition of face as follows.
About nucleic acid of the present invention, use term " isolating nucleic acid " sometimes.When being used for DNA, this term refers to isolating a kind of dna molecular from such sequence, its closely adjacent with this sequence (in 5 ' and 3 ' direction) in the genome of the natural appearance of this biology, and this dna molecular derives from this biology.For example, described " isolating nucleic acid " can comprise following dna molecular, and this DNA is inserted in the carrier such as plasmid or virus vector, perhaps is incorporated in prokaryotic organism or the Eukaryotic genomic dna." isolated nucleic acid molecule " also can comprise the cDNA molecule.
About RNA molecule of the present invention, term " isolating nucleic acid " originally refers to a kind of by the coded RNA molecule of the DNA isolation molecule of above-mentioned definition.In addition, this term can refer to a large amount of isolating RNA molecules from various RNA molecules, it is relevant with these RNA molecules to when native state (, in cell or tissue), and there be (term " pure basically " definition of face as follows) in this molecule with the form of " pure basically " as a result.
About albumen, use term " isolating albumen " or " albumen of separation and purifying " at this sometimes.Originally this term refers to the albumen by the expressed generation of isolated nucleic acid molecule of the present invention.In addition, this term can refer to a large amount of isolating albumen from other albumen, and it is relevant with these albumen natively, and this albumen exists with the form of " pure basically " as a result.
Term " pure basically " refer to a kind of purpose compound that comprises weight ratio 50-60% at least (as, nucleic acid, oligonucleotide, albumen etc.) prepared product.More preferably, this prepared product comprises the purpose compound of weight ratio 70% at least, and is most preferred for comprising the purpose compound of weight ratio 90-99%.Purity by the method that is suitable for this purpose compound measure (as, chromatography method, agarose or polyacrylamide gel electrophoresis, HPLC analyze, etc.).
About antibody of the present invention, term " immunology is special " refers to this antibody capable and combines with one or more epi-positions of target protein, but nonrecognition and in conjunction with other molecules that contain in the population mixture of antigen biomolecules basically.
About oligonucleotide, term " specific hybridization " refers to 2 combinations between the single stranded nucleic acid molecule with complementary sequence, with the above-mentioned hybridization (being also referred to as " complementary basically " sometimes) that allows to carry out under the general used predetermined condition in this area.Especially, this term refers to the hybridization of the complementary sequence basically that contains in a kind of oligonucleotide and single stranded DNA of the present invention or the RNA molecule, but gets rid of this oligonucleotide and the hybridization that contains the single-chain nucleic acid of incomplementarity sequence basically.
Term " inoculation cause of disease " refers to a kind of cause of disease to be inoculated to plant.
Term " the disease defence is replied " refers to the variation aspect metabolism, biosynthesizing vigor or genetic expression, and these variations can strengthen the ability of duplicating and propagating (that is, resisting this microorganism cause of disease) that plant suppresses the microorganism cause of disease.The example that plant disease defence is replied including, but not limited to, generation has the low-molecular weight compound (referring to phytoalexin) and induced defence (or relevant with defence) expression of gene of antimicrobial acivity, these products for example comprise peroxidase, cell wall protein, proteinase inhibitor, lytic enzyme, produce relevant (PR) albumen and phytoalexin biosynthetic enzyme with pathology, as phenylalanine ammonia base lyase and chalcone synthetase.As if in plant, above-mentioned disease defence is replied and is induced by several signal transduction pathways that relate to the secondary defence signal transmission molecule that produces in the plant materials.In plant, induce factor that disease defence replys including, but not limited to (1) microorganism cause of disease, as fungi, bacterium and virus; (2) microorganism component and other defence are replied and are caused son, as albumen and protein fragments, little peptide, elicitins and harpins, cryptogein and oligosaccharides; (3) the secondary defence signal that is produced by plant transmits molecule, as Whitfield's ointment, H
2O
2, ethene and jasmonate class.
Term " promoter region " refers to the regulatory region of gene 5 ' end.
Term " reporter gene " refers to and can be connected with promoter region steering quality and form genetically modified genetic sequence, and the expression of this gene coding region as a result is subjected to the adjusting of this promotor, and can be measured to this genetically modified expression easily.
Term " selectable marker gene " refers to when this kind genetic expression, gives by cell transformed or the selectable phenotype of plant, for example antibiotics resistance.
Term " steerable connection " means that encoding sequence expresses necessary adjusting sequence and place the proper site of dna molecular with respect to encoding sequence, thereby influences the expression of this encoding sequence.This identical definition also be applied to sometimes encoding sequence and transcriptional control element in the expression vector (as, promotor, enhanser and termination element) arrangement in.
Term " DNA construct " refers to and is used to the genetic sequence that transforms plant and produce the filial generation transgenic plant.These constructs can utilize virus or plasmid vector to use to plant.Wait other transmission methods such as the conversion of agrobatcerium T-DNA mediation and the conversion that utilizes biolistic to handle, also be considered to belong within the scope of the present invention.This transfering DNA can be according to the method preparation of standard, as (Frederick M.Ausubel et al. writes John Wiley﹠amp in " molecular biology modernism "; Sons, 1998) those methods of mentioning in the book.
The description of II .AVR1-CO39 and its coded polypeptide
According to the present invention, separated and cloned the virus-free gene of a kind of new i(magnaporthe grisea).This gene is referred to herein as AVR1-CO39, and its function is the special interaction of Cultivar of giving rice cultivar CO39.In embodiment 1, describe the clone in detail from the AVR1-CO39 gene of i(magnaporthe grisea) and analyzed this gene.As if this gene contains 4 and opens frame, and 1 (ORF3) wherein plays most critical giving aspect the special nontoxicity of the Cultivar of the i(magnaporthe grisea) chorista that carries this gene.The homology of bacterial strain 2539 chorista AVR1-CO39 genes is identified in the various arrangements of other i(magnaporthe grisea) choristas.
In the example of AVR1-CO39 of the present invention, the AVR1-CO39 genomic clone from i(magnaporthe grisea) bacterial strain 2539 is described in detail at this, and its nucleotides sequence is listed among the embodiment 1 as Sequence Identification number 1 and is suggested.Sequence Identification number 1 contains 4 and opens frame.It is generally acknowledged, by regulating sequence (embodiment 1) from opening the gene product that frame expresses or having crucial transcribing or translate, one or more these open frame and be responsible for giving Cultivar CO39 nontoxicity.
Although in this description and illustrate an AVR1-CO39 genomic clone from i(magnaporthe grisea) chorista 2539, but should think and the present invention includes nucleic acid and albumen from other i(magnaporthe grisea) choristas, quite similar when these nucleic acid and albumen use, can be by the AVR1-CO39 nucleic acid and the albumen of following purpose of description instead of separate body 2539.These choristas are including, but not limited to the allelic variant and the natural mutation of Sequence Identification number 1, and they might find in the colony of any i(magnaporthe grisea) chorista that provides.On Nucleotide and aminoacid sequence, have some difference because estimate above-mentioned variant, the invention provides the nucleic acid molecule of a kind of isolating AVR1-CO39, the nucleotide sequence that this molecule provides in coding region and Sequence Identification number 1 (and, most preferably, the special coding region that comprises Sequence Identification number 1) has about 60% sequence homology (be preferably 70% and more preferably surpass 80%) at least.What the present invention also provided Sequence Identification number 1 opens frame isolated polypeptide product, this product respectively with Sequence Identification numbers 2,3,4,5,6 or 7 aminoacid sequence has about 60% sequence homology (preferably 70% or 80% or bigger) at least.Owing to may have natural sequence variations in the AVR1-CO39 gene, those skilled in the art estimates to find the nucleotide sequence variation of about 30-40%, but these variations still keep the unique property of AVR1-CO39 gene and coded polypeptide of the present invention.A part of reason of above-mentioned prediction is the successful evolution of the degeneracy of codon and the variation of the conserved amino acid sequence known.Therefore, think that basically above-mentioned variant is identical with another variant, and be also included within the scope of the present invention.
Relevant purpose of the present invention, term " substantially the same " refers to Nucleotide or the aminoacid sequence with sequence variations, and these variations do not influence this proteic character (being its structure and/or biological activity) in fact.As for specific nucleotide sequence, term " substantially the same " can think that referring to the coding region also also refers to responsible conserved sequence of expressing, and refer to the degenerate codon of coding same amino acid at first, perhaps refer in encoded polypeptide and to be responsible for that coding is conservative replaces amino acid whose alternative codon.When relating to aminoacid sequence, term " substantially the same " refers generally to not influence the conservative property replacement and/or the variation of structure or function in the zone of this polypeptide.Term " percentage consistence " and " percentage similarity " also are used for the comparison between the aminoacid sequence of the present invention.Will be understood that these terms are defined, because they (Devereaux et al. nucleic acids research 12:387-397,1984) occur in UWGCG sequential analysis program, this routine analyzer can be buied from Wisconsin university.
Following description proposes to comprise enforcement general procedure of the present invention.As for the concrete material of mentioning, only be for the present invention is described, and can not think to limit the present invention.Unless the elsewhere specifies, can adopt conventional cloning process, as the method that in following book, proposes, Sambrooket al., molecular cloning, cold spring harbor laboratory (1989) (henceforth being " Sambrook etal. ") or Ausubel et al. (writing) molecular biology method, John Wiley﹠amp; Sons (1998) (henceforth being " Ausubel et al. ").A.AVR1-CO39 nucleic acid molecule, encoded polypeptides and the preparation that is specific to the antibody of this polypeptide
1. nucleic acid molecule
AVR1-CO39 nucleic acid molecule of the present invention can make by 2 kinds of usual ways: (1) they can be synthetic from suitable triphosphopyridine nucleotide, perhaps (2) they can from biomaterial, separate acquisition.The used step of 2 kinds of methods is well-known in this area.
Available nucleotide sequence information, the gene element that for example has Sequence Identification number 1 exsomatizes, and might prepare isolating nucleic acid molecule of the present invention by the oligonucleotide synthesis method.The synthetic oligonucleotide can be by the preparation of phosphinylidyne imines method, and this method is employed biosystem 38A syntheticization of DNA or similar equipment adopts.The construct that obtains can be according to method purifying well known in the art, as high performance liquid chromatography (HPLC).Because intrinsic volume restrictions in the present oligonucleotide synthesis method, long double stranded polynucleotide must progressively synthesize.Therefore, for example by several have a suitable complementarity can synthesize the duplex molecule of 1.05 kb than small segment.The complementary fragment of Chan Shenging can be annealed like this, and each fragment has had and is used for and suitable viscosity end that contiguous fragment is connected as a result.Under the dna ligase existence condition, these contiguous fragments couple together the duplex molecule of 1.05 kb of constructed total length by the annealing of sticky end.The synthetic dna molecule of method structure can be cloned and be increased in suitable carriers thus.
Use method well known in the art, also can from suitable biomaterial, separate the AVR1-CO39 gene.In one embodiment, can clone from i(magnaporthe grisea) 2539 bacterial strain cosmid library isolated genes groups.In an other embodiment, separablely comprise the cDNA clone that one or more AVR1-CO39 locus are opened frame.
According to the present invention,, can identify nucleic acid with sequence homology with the part or all of coding region of Sequence Identification number 1 by the hybridization and the cleaning condition of suitable strictness.For example, can hybridize according to the method for Sambrook et al., used hybridization solution contains: 5x SSC, 5x DenhardtShi reagent, 1.0%SDS, the salmon sperm DNA of the sex change fragmentation of 100 μ g/ml, 0.05% trisodium phosphate and up to 50% methane amide.Under 37-42 ℃, carry out 6 hours hybridization at least.After the hybridization, follow these steps to clean Hybond membrane: under (1) room temperature in 2x SSC and 1%SDS 5 minutes; (2) under the room temperature in 2x SSC and 0.1%SDS 15 minutes; Under (3) 37 ℃ in 2x SSC and 0.1%SDS 1 hour 30 minutes; (4) under 45-55 ℃ in 2X SSC and 0.1%SDS 2 hours, changed liquid every 30 minutes.In addition, the modifying method of Amasino hybridizing method (analytical biochemistry 152:304-307) is preferably used for the present invention and description in more detail in embodiment 1.
A common formula that is used to calculate stringent condition need obtain to have the hybridization (Sambrook et al., 1989) between the nucleic acid molecule of distinguished sequence homology:
T
m=81.5 ℃+16.6 Log[Na+]+0.41 (%G+C)-0.63 (% methane amide)-
600/#bp (in duplex)
As the explanation of above formula, with [N+]=[0.368] and 50% methane amide, and the average probe volume of 42% GC content and 200 bases, this T
mIt is 57 ℃.T in the DNA duplex
mValue descends 1-1.5 ℃ along with homology reduction by 1% thereupon.So,, can be observed the target thing bigger than about 75% sequence identity with 42 ℃ hybridization temperature.
Nucleic acid of the present invention can be in office what keep the form of DNA easily in the cloning vector.In a preferred embodiment, the clone is maintained in plasmid clone/expression vector, as pGEM-T (Promega Biotech, Madison, WI) or pBluescript (Stratagene, LaJolla, CA) carrier all can be bred in suitable e. coli host cell for every kind.
AVR1-CO39 nucleic acid molecule of the present invention comprises cDNA, genomic dna, RNA and its fragment, and these molecules can be strand or two strands.Therefore, the invention provides oligonucleotide (justice of DNA or RNA or antisense strand), this sequence energy and at least a sequence hybridization of selecting nucleic acid molecule provided by the present invention such as fragment as cDNA with I.D.No.1 sequence with following sequence.Above-mentioned oligonucleotide is as probe, by detect AVR1-CO39 gene or the mRNA in the specimen of fungi chorista as the pcr amplification method, perhaps before mRNA translates into albumen or in its process, regulate as the positive or negative of AVR1-CO39 genetic expression.
2. albumen
The AVR1-CO39 gene element that the present invention describes exsomatizes and contains 4 and open frame (ORF1-4), and its aminoacid sequence of being derived is represented with sequence I.D.No 2-5 respectively at this.Any these polypeptide can be prepared according to the method for knowing.If original position produces, institute's polypeptide that obtains can be from as purifying the suitable materials such as fungi chorista.
In addition, the availability of the nucleic acid molecule of these polypeptide of encoding makes that using vivoexpression method well known in the art to produce described albumen becomes possibility.For example, can be in a kind of suitable in-vitro transcription carrier cDNA or gene clone, as be suitable for the pSP64 or the pSP65 of in-vitro transcription, in a kind of suitable cell free translation system such as wheat germ or rabbit reticulocyte, carry out acellular translation then.In-vitro transcription and translation system can obtain from commercial channels, as can from Promga Biotech (Madison, Wisconsin) or BRL (Rockville Maryland) obtains.
According to an embodiment preferred, relatively large AVR1-CO39 encoded polypeptides can be expressed generation in suitable prokaryotic organism or eukaryote system.For example, part or all of dna molecular, can be inserted in a kind of plasmid vector that is suitable in bacterial cell (as intestinal bacteria) or yeast cell (as yeast saccharomyces cerevisiae) expressing such as cDNA, perhaps be inserted into and be suitable in the baculovirus vector of expressed in insect cells with sequence I.D.No.1.Above-mentioned carrier contains this DNA expresses necessary regulatory element in host cell, its locator means allows this DNA to express in host cell.The necessary regulatory element of above-mentioned expression comprises promoter sequence, transcriptional initiation sequence and can select enhancer sequence.
The AVR1-CO39 polypeptide that is produced by genetic expression in prokaryotic organism of recombinating or eukaryote system can carry out purifying according to method well known in the art.In a preferred embodiment, the expression/excretory system that adopts commercial sources to obtain, this recombinant protein is expressed thus, is secreted into then outside the host cell, easily purifying from substratum on every side.If need not express/secretion vector, a kind of alternate method comprises by affine this recombinant protein of partition method purifying, for example by with the antibody mediated immunity interaction purifying of this recombinant protein of specific combination.Experienced operators is often used aforesaid method.
By the AVR1-CO39 encoded polypeptides of the present invention of method preparation above-mentioned, can analyze according to standard program.The method of analytic function activity (promptly giving avirulent ability) is described in embodiment 1.
The present invention also provides immunity specifically in conjunction with the antibody of polypeptide of the present invention.Directly, can prepare according to standard method at polyclone or monoclonal antibody by any peptide of the ORFs coding of AVR1-CO39.According to the general method of K hler and Milstein, the operation steps of following standard prepares monoclonal antibody.In a preferred embodiment, prepared various antibody, the various epi-positions of these antibody capables and AVR1-CO39 encoded polypeptides play immune response specifically.
Immunity specifically with one or more by interactional polyclone of AVR1-CO39 encoded polypeptides or monoclonal antibody, can be used for differentiating and the above-mentioned albumen of purifying.For example, can be used for affine separation energy and the interactional specifically albumen of its immunity to antibody.The albumen that also can be used for antibody the blend sample of self-contained albumen of immunoprecipitation and other biological molecule.Other purposes of antibody are described below.
The purposes of the nucleic acid of B.AVR1-CO39, proteins encoded and antibody
The genetic recombination engineering method is used to strengthen the potentiality that agricultural goes up the disease resistance of important plant, has obtained a large amount of concerns in recent years.Many effective meanss are arranged at present, be used for stable gene ground is imported plant and is used for reinforcing gene expression.The invention provides multiple nucleic acid molecule, these molecules are stably imported to recipient plant or import to grow nonparasitically upon another plant in the microorganism of plant after, can strengthen the ability of the opposing cause of disease invasion and attack of plant.AVR1-CO39 proteins encoded of the present invention also directly is used for plant, replys with inducing anti-disease.
1.AVR1-CO39 nucleic acid
According to the present invention, AVR1-CO39 nucleic acid (genomic clone or cDNAs) can be used for various purposes.This DNA, RNA or its fragment can be used as probe, to detect existing and/or the genetic expression of AVR1-CO39 of AVR1-CO39 gene.AVR1-CO39 nucleic acid is included, but are not limited to as the method that probe carries out said determination: (1) in situ hybridization; (2) southern hybridization; (3) northern hybridization; (4) similar amplified reaction such as polymerase chain reaction (PCR).AVR1-CO39 nucleic acid of the present invention also can be used as probe, to identify the homologue from other i(magnaporthe grisea) choristas.As described above, AVR1-CO39 nucleic acid also is advantageously used in and produces a large amount of pure basically AVR1-CO39 albumen or its selected part.
But, perhaps the purposes of the bigger meaning of AVR1-1039 nucleic acid is a resistance spectrum of widening the rice cultivar that carries the CO39 resistant gene, and this resistance is at antigen rather than carry the i(magnaporthe grisea) chorista of AVR1-1029 non-toxic gene.For example, in one embodiment of the invention, be connected with a kind of allogeneic promoter to AVR1-CO39 coding region steering quality, preferably this promotor generally can be by pathogeny evoked (that is, can be excited by the cause of disease of broad range induce) or can be by wound-induced.Above-mentioned promotor includes, but are not limited to:
A) promotor of coding fat oxygenase gene is (preferably from plant, most preferably from paddy rice, for example, Peng et al., journal of biological chemistry 269:3755-3761,1994:Peng et al., Abstract presented at the general meeting ofthe International Program on Rice Biotechnology, Malacca, Malaysia, Sept.15-19,1997);
B) promotor of coding peroxidase gene (preferably from plant, most preferably from paddy rice, for example, Chittoor et al., Mol.Plant-MicrobeInteractions 10:861-871,1997);
C) promotor of coding hydroxymethyl glutaryl base-CoA reductase gene (preferably from plant, most preferably from paddy rice, for example, Nelson et al., Plant Mol.Biol.25:401-412,1994);
D) promotor of coding phenylalanine ammonia base lyase gene is (preferably from paddy rice, for example, Lamb et al., Abstract of the general meeting of theInternational Program on Rice Biotechnology, Malacca, Malaysia, Sept.15-19,1997);
E) promotor of coding for glutathion transferase gene (preferably from plant, most preferably from paddy rice, or in addition, from the PRP1 promotor of potato);
F) from the promotor of pollen-specific gene, as corn Zmg13, shown and in carrying the paddy rice transgenosis pollen of corn gene, expressed (Aldemita et al., Abstractof the general meeting of the International Program on RiceBiotechnology, Malacca, Malaysia, Sept.15-19,1997);
G) promotor of chitinase encoding gene (preferably from plant, most preferably from paddy rice, for example, Zhu﹠amp; Lamb, Mol.Gen.Genet.226:289-296,1991);
H) in the interaction of i(magnaporthe grisea) and paddy rice the promotor of early stage (inoculating in back 5 hours) inductive gene (as, Bhargava﹠amp; Hamer; Abstract B-10,8th International Congress Molecular Plant MicrobeInteractions, Knoxville, TN July 14-19,1996);
I) from the promotor of plant (being preferably paddy rice) virogene, as Hammond-Kosack et al., described in the Mol.Plant-Microbe Interactions 8:181-185 (1994), these genes are included in bacterial plasmid or plant viral vector;
J) from the promotor of the gene that relates to plant (being preferably paddy rice) respiratory burst (as, Groom et al., Plant is (3) J.10: 515-522,1996); With
K) from the promotor of the gene that relates to plant (being preferably paddy rice) cyanin path (as, Reddy, pp341-352 in Rice Genetics III, supra; Reddy, et al..Abstract of the general meetlng of the InternationalProgram on Rice Biotechnology, Malacca, Malaysia, Sept.15-19,1997)。
This mosaic gene is used to transform the rice cultivar that has carried the suitable R gene then.With the pathogenic wound or after exciting, can induce transgenic plant to produce the AVR1-CO39 gene product, excite the defence of R gene to reply thus.In this embodiment, must be noted that and avoid using the promotor that is subjected to necrosis induction, because use above-mentioned promotor can cause constantly lethal super quick the replying of plant (as seeing, Kim et al., institute of NAS reports 91:10445-10449,1994).
In a preferred embodiment, the coding region of AVR1-CO39 (preferably with ORF3 respective coding district) is inserted in the expression vector of a kind of microorganism, and this microorganism grows nonparasitically upon another plant and grows on rice plant.The suspension of above-mentioned recombinant microorganism is sprayed on the rice cultivar that carries suitable R gene.After the cause of disease invasion and attack, the provide protection of 2 kinds of levels may occur: (1) excites plant surface to change by this reorganization gene product that body produces of growing nonparasitically upon another plant, further stop the penetrating of this cause of disease (as, the conidium of this fungi develops into the spore of growing nonparasitically upon another plant, but aplasia becomes peg); Perhaps (2) are brought in the plant tissue of wound site by this reorganization gene product that body produces of growing nonparasitically upon another plant, and it interacts with corresponding R gene product and the disease defence of induced internal is replied there.So this pre-treatment is given the Dui Geshi Magna and protected the plucked instrument bacterium chorista resistance of (with may other pathogenic), normal, these cause of diseases are that tool is toxic to those Cultivars.The present embodiment is described in embodiment 3 in more detail.
As for growing nonparasitically upon another plant in the purposes of the bacterium of plant, should note expression and the transmission system of bacterium and phage,, be particularly useful from the kind that InVitrogen buys as those commercial sources.Bacterial system is expressed albumen a kind of and pilin hybridization, and this foreign protein is exposed to the outside of bacterial body as a result.This phage system also expresses a kind of albumen and foreign protein with the hybridization of shell component and is exposed to the outside.
This AVR1-CO39 gene also can be used as a kind of instrument, identifies and separates its corresponding R gene.Therefore, with the tomato CF-9 gene that separates dark yellow branch spore resistance (Joneset al. is described, science 266:789-793,1994) method is similar, and the R gene corresponding to AVR1-CO39 in the paddy rice can separate by transposon tagging: (1) is transformed into AVR1-CO39 in the responsive rice strain and the constructive expression; (2) this transgenic strain and the resistant strain hybridization of carrying appraisable transposon; (3) carrying the F1 filial generation seedling of constructive expression Avr gene and corresponding R gene should be dead, thereby has and can screen F1 filial generation alive simply; (4) by disturbing AVR1-CO39 transgenosis or corresponding R gene, perhaps by transposon, the F1 filial generation of any work should be survived.So can separate and the relevant transposon of this gene of interference.
2.AVR1-CO39 albumen and antibody
AVR1-CO39 gene product or its fragment of purifying can be used for producing polyclone or monoclonal antibody, these antibody also can be used as responsive detection reagent, detect the existence and the accumulation of AVR1-CO39 polypeptide in microorganism transformed epiphyte body, transgenic plant or other biological material.Immunity can be used for the method for various design detections and quantitative analysis of protein specifically at the polyclone or the monoclonal antibody of AVR1-CO39 polypeptide.Aforesaid method is including, but not limited to (1) flow cytometry; (2) immunochemistry of expressing protein location in cell or tissue; And (3) to from the immunoblotting assay of various cells and tissue extract (as, dot blotting or Western trace).In addition, as mentioned above, can be used for purifying AVR1-CO39 polypeptide (as affinity column purifying, immunoprecipitation) to antibody.
In a preferred embodiment, the AVR1-CO39 polypeptide of purifying (most preferred from ORF3) is used as pre-treatment or co-processing agent, gives the rice cultivar broad-spectrum disease resistance that carries CO39 R gene originality.Therefore, can to express growing nonparasitically upon another plant of AVR1-CO39 similar in the method for microorganism of plant to above-mentioned use, with pathogenic micro-organism wound or wound or inoculation simultaneously subsequently, this polypeptide contacted with the R gene product, thereby excited and defend to reply.The present inventor shows by experiment, and as embodiment 4 was described in detail, present method had feasibility.
Following specific embodiment explanation embodiment of the present invention are provided.In any case can not think that these embodiment limit the scope of the invention.
Embodiment 1
The clone of AVR1-CO39 and analysis
Use carries out chromosome walking method (Leong etal., 1996) then based on the cloning process of collection of illustrative plates, separated the chromosome segment that a supposition contains Cultivar specific gene AVR1-CO39 from i(magnaporthe grisea) bacterial strain 2539.In the present embodiment, we have described discriminating, clone and the analysis of AVR1-CO39 gene.
Method:
Hybridizing method is that the method that Amasino (1986) " quickens nucleic acid hybridization rate, analytical biochemistry 152:304-307 by polyoxyethylene glycol " is slightly made an amendment to hybridizing method.Method according to Amasino prepares hybridization buffer, but does not add PEG and NaCl, and reduces NaHPO
4Concentration: 0.125 M NaHPO
4, 7%SDS, 50% methane amide, 1.0mM EDTA, pH 7.2.Use high stringent condition (42 ℃, 16h).Wash the method for film after the hybridization: wash 1 time with 2XSSC under the room temperature, in 2XSSC, wash altogether 10min 1 time for 65 ℃, in 2XSSC, wash 15min altogether 1 time for 65 ℃, at last in 0.1 X SSC, 0.1%SDS 65 ℃ wash 15min altogether 1 time.The last film condition of washing is stricter than hybridization conditions, the T of setting
mValue is 68.So just need be than 95% bigger homology in order to keep crossbred.Describe in the method for (1986) at Amasino, do not use the phosphatic damping fluid in hybridization back.
The chromosome walking strategy is built among clay pMLF1 (Leong et al., the same) and the pMLF2 (An et al., gene 17 6:93-96,1996) by the total genomic dna library of the i(magnaporthe grisea) bacterial strain 2539 of 5,194 clone's compositions.As the template of colony trace and clone's set, wherein electrophoresis and trace are carried out in this being limited property of DNA digestion to these clones one by one.The latter's trace contains the candidate clone set that hybridization is cloned as initial the evaluation.Screen colony trace point then from these clone's set.Carry out following steps, utilize Apa I digestion clay clone, preparation is from the end clone who inserts DNA, and the Apa I can not digest this carrier, then by connecting this plasmid of recirculation.This step produces a kind of two ends and all has the derivative (An etal., 1996 is the same) that inserts segmental DNA.By with Apa I and the digestion of Not I, obtain from segmental 2 ends of the insertion of this carrier.Then, rely on its move in the step in can not with before the characteristic of clay hybridization, identify the end clone who obtains.
Transform virulent strain Guy11 with the clay in the AVR1-CO39 locus: the method for transformation that adopts LEUNGet al. (1990) to describe, importing among the Guy11 from the heredity clay at interval that contains AVR1-CO39.This step is carried out following modification: protoplastis injects (45 ℃) CM+20% sucrose agar that 100ml melts to them behind perfect medium (CM)+sorbyl alcohol incubation.Then, agar is poured in 4 culture dish.When this agar solidifies (1h), cover the 1.5% water agar that contains 800 μ g/ml hygromycin B (final concentration is 300 μ g/ml) above with 15ml.
Opening in the frame of AVR1-CO39 locus cause phase shift mutation the 1.05kb fragment cloning to the pBSKS II
+(pBSCO39) in to make 2 initial clones.Then, the 1.05kb fragment cloning of this sudden change to from the pCB1004 hyg of J.Sweigard (Dupont)
rIn the carrier.Make plasmid linearization and be transformed in the Guy11 protoplastis with Not I digestion.
By the digestion of following method with reconnect, in ORFs 2 and 3, produce initial phase shift mutation:
Phase shift mutation in ORF2: downcut in the Acc I site of 499 in Nucleotide (nt), cut 2 nt of 3 ' overhangs with the T4 archaeal dna polymerase.Reconnect this site then, the result has removed 4 bp or clean frameshit-2.This nucleotide sequence is changed into 5 ' CTAGACAGTACCTCTCTGCCA3 ' (SEQ ID NO:10) from 5 ' CTAGACAGTCTACCTCTCTGCCA, 3 ' (SEQ ID NO:9).
At ORFS 2﹠amp; Phase shift mutation in 3: downcut in the pflM I site of 641 of nt, cut 3 nt of 3 ' overhangs with the T4 polysaccharase.Contain the Hind III fragment of a klenow filling of streptomycin resistance gene box from pHP45 Ω (Prentki and Kritsch, gene 29:303,1984), be connected on the pflM I fragment of blunt end.Digest then and reconnect this conservative Hind III site.Its net effect is 3 nt that use from 4 nt replacement pflM I sites in the Hind III site.This has produced clean frameshit+1.This nucleotide sequence is changed into 5 ' CCAGCAGCCAAAGCTTTGGAAAGATTG3 ' (SEQ ID NO:12) from 5 ' CCAGCAGCCAATGCTTGGAAAGATTG, 3 ' (SEQ IDNO:11).
In Δ Acc I construct, described peptide only keeps 19 amino acid of its original series and has clipped 36 amino acid afterwards.Natural ORF2 peptide is 77 amino acid.In Δ Pf1 construct, except terminal 10 amino acid, this ORF2 peptide sequence is almost without any variation, and the polypeptide that obtains is than 17 amino acid of original length.On the other hand, ORF3 only keeps from 20 amino acid of its N-end and stops behind 31 amino acid.
By " speed become " site-directed mutagenesis method (Stratagene), after ATG, import the primer of an extra G Nucleotide with following design, caused the phase shift mutation in ORF1:
P1:CAACGTACTAGAAATGGAGTAATAAGTACC(SEQ?ID?NO:13)
P2:GGTACTTATTAGTCCATTTCTAGTACGTTG(SEQ?ID?NO:14)
This mutagenesis is eliminated described ORF basically fully.
Cause ATG in the frame opening of AVR1-CO39 locus and suddenly change the 1.05kb fragment cloning that contains AVR1-CO39 in pCB1004, and make following sudden change construct with speed change (quick change) mutagenesis (Stratagene):
Δ ORF1 (ATG → TTT): become mutagenesis by speed, eliminate the initiator codon of ORF1 with primer with sudden change ATG sequence.
Δ ORF3 (ATG → TTT): become mutagenesis by speed, eliminate the initiator codon of ORF3 with primer with sudden change ATG sequence.
Make following clone, but do not detected the allelotrope of sudden change by the transformation assay phenotype yet.
Δ ORF2 (ATG → TTT): become mutagenesis by speed, eliminate the initiator codon of ORF2 with primer with sudden change ATG sequence.
The result:
As above-mentioned; Use cloning process based on collection of illustrative plates; Carry out 20 step chromosome walkings then; From i (magnaporthe grisea) bacterial strain 2539; Separate a kind of gene; this gene is given the interaction special with the Cultivar of rice cultivar CO39.By the subclone method and transform Guy11 ( a kind of bacterial strain that normally CO39 is had virulence ) and become nontoxicity, make the AVR1-CO39 locus go to limit to 1.05kb district.11.05kbSEQ ID NO:1:GATCTGTAAA TTACATATAT TTATTTTGCC GCATTTTGCT AACCGCCTATTCTTTTTAAA ATTTTAACGA TTAAGAACGC AATTCAATTT TGCGTTCTACACAAATTAAC AATTCGTCCA AAAGAGGTAT TTAAGCGAAG ATTTGGCATTTTTTTAATCC ATTTTTAAAA AAATACATCT GCTTTAACCC ACCTTTGCCAAGGGTACCCG GCTAGCATAG CCTTGGTTAC CAAAAACGGC TAAAGCTGTCGATCTATACT ACATTCGGCG CTCTGAACAA CTAAGCAACA GCGAGGAGAT T5CACACCCTAA ATCATGCTGC TAGTAATGCG ATATAATGGC CAAACAACGT ORF1→ACTAGAAATG ACTAATAAGT ACCCAGTCAA GTCAACTTGC TGTAGTATTA ←ORF5 ORF2→TATTTAACGA AGCGTCCATT TACTGCCAGG GCAAGTTTAT CAATGGGACC T1AGTGTTCTCC CTCCTCTGGA CAACTCAGTT CTTTGCAAAC GCTAGACAGTCTACCTCTCT GCCACCATTT TTACTTTTCA AAAATTTACT CCTTGCCGCT T4 ORF3→ACTGAAACTT CTACAATTGA AAGAGCCCAC AATGAAAGTC CAAGCTACATTCGCCACCCT TATCGCCCTT GCGGCTTACT TTCCAGCAGC CAATGCTTGG T2AAAGATTGCA TCATCCAACG TTATAAAGAC GGCGATGTCA ACAACATATATACTGCCAAT AGGAACGAAG AGATAACTAT TGAGGAATAT AAAGTCTTCG ORF6→ ←ORF4TTAATGAGGC CTGCCATCCC TACCCAGTTA TACTTCCCGA CAGATCGGTC T3CTTTCTGGCG ATTTTACATC AGCTTACGCT GACGACGATG AGTCTTGTTG T6 ORF7→ATCAATAAGA GTCCAGGTTG AAAAATTCGC CACCATGGTA ATAGAGGGTTATTTATCTCG GAATAGCAGC CGTGTGTGCA ATTATCACGG CTGTTCCTCTGCGATAGGGA TATTAGAAGC AGGACAAATT TACGGCAATA GCAACCAATTGTCCTTGTCT ATGGATTCGC CCGTCGAATG GAGGCGACGG CGGATCC
Dna sequence analysis has shown that 4 length are 45,77, the 89 and 69 amino acid whose frames (shown in top SEQ ID NO:1, being respectively ORF1, ORF2, ORF3, ORF4) of opening for a short time.Open the frame amino acid sequence coded by these 4 and be expressed as following ID NO.2,3,4 and 5 respectively.Also identified 3 other open frame (ORFS 5,6 and 7 is expressed as following SEQ ID NOS:6,7 and 8 respectively).AVR1-CO39?ORF1?(SEQ?ID?NO:?2)
MTNKYPVKST?CCSIIFNEAS?IYCQGKFING?TSVLPPLDNS
VLCKRAVR1-CO39?ORF2?(SEQ?ID?NO:?3)
MGPVFSLLWT?TQFFANARQS?TSLPPFLLFK?NLLLAATETS
TIERAHNESP?SYIRHPYRPC?GLLSSSQCLE?RLHHPTLAVR1-CO39?ORF3?(SEQ?ID?NO:?4)
MKVQATFATL?IALAAYFPAA?NAWKDCIIQR?YKDGDVNNIY
TANRNEEITI?EEYKVFVNEA?CHPYPVILPD?RSVLSGDFTS
AYADDDESCAVR1-CO39?ORF4?(SEQ?ID?NO:?5)
MAGLINEDFI?FLNSYLFVPI?GSIYVVDIAV?FITLDDAIFP
SIGCWKVSRK?GDKGGECSLD?FHCGLFQLAVR1-CO39?ORF5?(SEQ?ID?NO: 6)
MDASLNIILQ?QVDLTGYLLV?ISSTLFGHYI?ALLAAAVR1-CO39?ORF6?(SEQ?ID?NO: 7)
MRPAIPTQLY?FPTDRSFLAI?LHQLTLTTMS?LVDQAVR1-CO39?ORF7?(SEQ?ID?NO:?8)
(after clone's DNA, continuing)
4 around the ATG of ORF3 in sequence and 5 the conservative bases that find in the fungi translation initiation site are complementary, and contain one at the position 2 terminal and 2 supposition cracking sites that are used to remove signal peptide of hydrophobic amino that are interrupted by Methionin.On another relative chain, identified the 4th and opened frame (ORF4).Yet the sequence around the ATG only contains the sequence that 2 concensus sequences with the fungi translation initiation site are complementary.
In order to estimate the effect of these ORF in giving nontoxicity, in ORF1, ORF2 and ORF3, made rite-directed mutagenesis.The translation initiation codon of each ORF changes TTT into by ATG.In ORF 1 and 3, these sudden changes cause avirulent losing.Phase shift mutation in ORF1 and ORF3 also causes avirulent losing, and the phase shift mutation in ORF 2 does not cause avirulent losing.In sum, these data show ORF1 and the effect of ORF3 in giving rice cultivar CO39 Dui Geshi Magna guarantor plucked instrument bacterium nontoxicity.
The TATA element that lacks any supposition in ATG upstream of shearing site and lasso trick sequence and next-door neighbour ORF1 may show that the sequence that ORF1 and transcripting starting to AVR1-CO39 play a crucial role overlaps.
The distribution of the AVR1-CO39 homologue of embodiment 2 in various i(magnaporthe grisea) choristas
Those hybridization conditions of using as describing in embodiment 1 are surveyed the sample of the i(magnaporthe grisea) form of a large amount of host specifics with the AVR1-CO39 dna fragmentation, to study the distribution of AVR1-CO39 homologue.The result of this research shows, infects the homologue of the most of Avr-CO39 of shortage of chorista of paddy rice Digitaria and wheat.But, the homologue of this gene finds in the chorista that infects Elutine (Setaria) usually.Moreover, the detailed analysis from the locus of paddy rice toxicity chorista Guy 11 is shown, corresponding and contain the DNA incompleteness that has 20 kb at least of the AVR1-CO39 locus of chorista 2539.
Embodiment 3
Bacterium epiphyte body spray water rice plants with the ORF3 that expresses AVR1-CO39 improves the resistance that the Dui Geshi Magna is protected the infection of plucked instrument bacterium
The ORF3 of the AVR1-CO39 that describes in embodiment 1 is transferred in the colibacillary pET expression vector.The suspension that contains transformed into escherichia coli, be sprayed onto on the leaf that carries at the rice plant of the corresponding R gene of AVR1-CO39.Then, these plant are that a kind of plant growing kind to detection has toxic bacterial strain with i(magnaporthe grisea) chorista Guy11 inoculation, Guy11.In contrast, other plant are sprayed with the intestinal bacteria suspension of the plasmid that does not contain ORF3, then with chorista Guy11 inoculation.
With compare with the pretreated inoculation adjoining tree of the intestinal bacteria of the plasmid that lacks ORF3, show as the damaged area and the number of reduction with the pretreated inoculation plant of intestinal bacteria of expression ORF3.These data can be supported the effect of ORF3 in giving Dui Geshi Magna guarantor plucked instrument bacterium nontoxicity.
Embodiment 4
ORF3 encoded protein spray water rice plants with AVR1-CO39 improves the resistance that the Dui Geshi Magna is protected the infection of plucked instrument bacterium
The ORF3 of the AVR1-CO39 that describes in embodiment 1 is transferred in the colibacillary pET expression vector.To toxic influence, these Bacillus coli cells carry and only contain pET carrier (contrast) or pET-ORF3 construct from the colibacillary albumen extract of IPTG inductive in detection.The cell protein extract concentrates by ammonium sulfate precipitation.Unite the inoculation to Cultivar CO39 with toxicity i(magnaporthe grisea) bacterial strain Guy11 and spissated albumen extract, consumption is to contain 5x10 in the 10ml sterilized water
5Individual conidium and 20mg total protein.
Compare with the inoculation adjoining tree that crosses with the albumen co-processing that lacks ORF3, the inoculation plant that crosses with the albumen extract co-processing that contains ORF3 shows as the area and the number of the damage of reduction.These data can be supported the effect of ORF3 in giving Dui Geshi Magna guarantor plucked instrument bacterium nontoxicity process.
Although disclosed embodiment preferred more of the present invention and in addition concrete illustrating, can not think that the present invention is confined to above-mentioned embodiment.Therefore the method that proposes according to following claim can be made various amending methods, and these methods do not depart from scope and spirit of the present invention.
Sequence table<110〉Sally A.Leong Mark L.Farman
<120〉from the Cultivar specific gene and methods for using them of rice pathogen i(magnaporthe grisea)
<130>WARF?P98067WO
<150>US60/075,925
<151>1998-02-25
<160>14
<170>FastSEQ?for?Windows?Version?3.0
<210>1
<211>1047
<212>DNA
<213〉i(magnaporthe grisea)
<400>1gatctgtaaa?ttacatatat?ttattttgcc?gcattttgct?aaccgcctat?tctttttaaa 60attttaacga?ttaagaacgc?aattcaattt?tgcgttctac?acaaattaac?aattcgtcca 120aaagaggtat?ttaagcgaag?atttggcatt?tttttaatcc?atttttaaaa?aaatacatct 180gctttaaccc?acctttgcca?agggtacccg?gctagcatag?ccttggttac?caaaaacggc 240taaagctgtc?gatctatact?acattcggcg?ctctgaacaa?ctaagcaaca?gcgaggagat 300cacaccctaa?atcatgctgc?tagtaatgcg?atataatggc?caaacaacgt?actagaaatg 360actaataagt?acccagtcaa?gtcaacttgc?tgtagtatta?tatttaacga?agcgtccatt 420tactgccagg?gcaagtttat?caatgggacc?agtgttctcc?ctcctctgga?caactcagtt 480ctttgcaaac?gctagacagt?ctacctctct?gccaccattt?ttacttttca?aaaatttact 540ccttgccgct?actgaaactt?ctacaattga?aagagcccac?aatgaaagtc?caagctacat 600tcgccaccct?tatcgccctt?gcggcttact?ttccagcagc?caatgcttgg?aaagattgca 660tcatccaacg?ttataaagac?ggcgatgtca?acaacatata?tactgccaat?aggaacgaag 720agataactat?tgaggaatat?aaagtcttcg?ttaatgaggc?ctgccatccc?tacccagtta 780tacttcccga?cagatcggtc?ctttctggcg?attttacatc?agcttacgct?gacgacgatg 840agtcttgttg?atcaataaga?gtccaggttg?aaaaattcgc?caccatggta?atagagggtt 900atttatctcg?gaatagcagc?cgtgtgtgca?attatcacgg?ctgttcctct?gcgataggga 960tattagaagc?aggacaaatt?tacggcaata?gcaaccaatt?gtccttgtct?atggattcgc 1020ccgtcgaatg?gaggcgacgg?cggatcc 1047
<210>2
<211>45
<212〉protein
<213〉i(magnaporthe grisea)
<400>2Met?Thr?Asn?Lys?Tyr?Pro?val?Lys?Ser?Thr?Cys?Cys?Ser?Ile?Ile?Phe?1 5 10 15Asn?Glu?Ala?Ser?Ile?Tyr?Cys?Gln?Gly?Lys?Phe?Ile?Asn?Gly?Thr?Ser
20 25 30Val?Leu?Pro?Pro?Leu?Asp?Asn?Ser?Val?Leu?Cys?Lys?Arg
35 40 45
<210>3
<211>77
<212〉protein
<213〉i(magnaporthe grisea)
<400>3Met?Gly?Pro?Val?Phe?Ser?Leu?Leu?Trp?Thr?Thr?Gln?Phe?Phe?Ala?Asn1 5 10 15Ala?Arg?Gln?Ser?Thr?Ser?Leu?Pro?Pro?Phe?Leu?Leu?Phe?Lys?Asn?Leu
20 25 30Leu?Leu?Ala?Ala?Thr?Glu?Thr?Ser?Thr?Ile?Glu?Arg?Ala?His?Asn?Glu
35 40 45Ser?Pro?Ser?Tyr?Ile?Arg?His?Pro?Tyr?Arg?Pro?Cys?Gly?Leu?Leu?Ser
50 55 60Ser?Ser?Gln?Cys?Leu?Glu?Arg?Leu?His?His?Pro?Thr?Leu65 70 75
<210>4
<211>89
<212〉protein
<213〉i(magnaporthe grisea)
<400>4Met?Lys?Val?Gln?Ala?Thr?Phe?Ala?Thr?Leu?Ile?Ala?Leu?Ala?Ala?Tyr1 5 10 15Phe?Pro?Ala?Ala?Asn?Ala?Trp?Lys?Asp?Cys?Ile?Ile?Gln?Arg?Tyr?Lys
20 25 30Asp?Gly?Asp?Val?Asn?Asn?Ile?Tyr?Thr?Ala?Asn?Arg?Asn?Glu?Glu?Ile
35 40 45Thr?Ile?Glu?Glu?Tyr?Lys?Val?Phe?Val?Asn?Glu?Ala?Cys?His?Pro?Tyr
50 55 60Pro?Val?Ile?Leu?Pro?Asp?Arg?Ser?Val?Leu?Ser?Gly?Asp?Phe?Thr?Ser65 70 75 80Ala?Tyr?Ala?Asp?Asp?Asp?Glu?Ser?Cys
85
<210>5
<211>68
<212〉protein
<213〉i(magnaporthe grisea)
<400>5Met?Ala?Gly?Leu?Ile?Asn?Glu?Asp?Phe?Ile?Phe?Leu?Asn?Ser?Tyr?Leu1 5 10 15Phe?Val?Pro?Ile?Gly?Ser?Ile?Tyr?Val?Val?Asp?Ile?Ala?Val?Phe?Ile
20 25 30Thr?Leu?Asp?Asp?Ala?Ile?Phe?Pro?Ser?Ile?Gly?Cys?Trp?Lys?Val?Ser
35 40 45Arg?Lys?Gly?Asp?Lys?Gly?Gly?Glu?Cys?Ser?Leu?Asp?Phe?His?Cys?Gly
50 55 60Leu?Phe?Gln?Leu65
<210>6
<211>35
<212〉protein
<213〉i(magnaporthe grisea)
<400>6Met?Asp?Ala?Ser?Leu?Asn?Ile?Ile?Leu?Gln?Gln?Val?Asp?Leu?Thr?Gly1 5 10 15Tyr?Leu?Leu?Val?Ile?Ser?Ser?Thr?Leu?Phe?Gly?His?Tyr?Ile?Ala?Leu
20 25 30?Leu?Ala?Ala
35
<210>7
<211>34
<212〉protein
<213〉i(magnaporthe grisea)
<400>7Met?Arg?Pro?Ala?Ile?Pro?Thr?Gln?Leu?Tyr?Phe?Pro?Thr?Asp?Arg?Ser?1 5 10 15Phe?Leu?Ala?Ile?Leu?His?Gln?Leu?Thr?Leu?Thr?Thr?Met?Ser?Leu?Val
20 25 30Asp?Gln
<210>8
<211>54
<212〉protein
<213〉i(magnaporthe grisea)
<400>8Met?Va1?Ile?Glu?Gly?Tyr?Leu?Ser?Arg?Asn?Ser?Ser?Arg?Val?Cys?Asn?1 5 10 15Tyr?His?Gly?Cys?Ser?Ser?Ala?Ile?Gly?Ile?Leu?Glu?Ala?Gly?Gln?Ile
20 25 30Tyr?Gly?Asn?Ser?Asn?Gln?Leu?Ser?Leu?Ser?Met?Asp?Ser?Pro?Val?Glu
35 40 45Trp?Arg?Arg?Arg?Arg?Ile
50
<210>9
<211>23
<212>DNA
<213〉i(magnaporthe grisea)
<400>9ctagacagtc?tacctctctg?cca
<210>10
<211>21
<212>DNA
<213>Magnaporthe?grisea
<210>10
<211>21
<212>DNA
<213〉i(magnaporthe grisea)
<400>10ctagacagta?cctctctgcc?a
<210>11
<211>26
<212>DNA
<213〉i(magnaporthe grisea)
<400>11ccagcagcca?atgcttggaa?agattg
<210>12
<211>27
<212>DNA
<213〉i(magnaporthe grisea)
<400>12ccagcagcca?aagctttgga?aagattg
<210>13
<211>30
<212>DNA
<213〉i(magnaporthe grisea)
<400>13caacgtacta?gaaatggagt?aataagtacc
<210>14
<211>30
<212>DNA
<213〉i(magnaporthe grisea)
<400>14ggtacttatt?agtccatttc?tagtacgttg
Claims (29)
1. one kind from the i(magnaporthe grisea) isolated nucleic acid molecule, and described nucleic acid molecule is given rice cultivar CO39 to containing the special nontoxicity of fungoid pathogenic of this nucleic acid.
2. the nucleic acid molecule of claim 1, this nucleic acid molecule is AVR1-CO39.
3. the nucleic acid molecule of claim 2, the sequence of this nucleic acid molecule comprises part or all of SEQ ID NO:1.
4. the nucleic acid molecule of claim 1, the polypeptide of this nucleic acid molecule encoding are characterised in that and comprise the sequence that is selected from down group: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7 and SEQ ID NO:8.
5. the nucleic acid molecule of claim 4, the polypeptide of this nucleic acid molecule encoding comprise the sequence that is selected from down group: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7 and SEQ ID NO:8.
6. recombinant DNA molecules comprises the nucleic acid molecule of the claim 1 that manipulative capability ground is connected with the carrier that is used for transformant.
7. recombinant DNA molecules cell transformed with claim 6.
8. the cell of claim 7, this cell is selected from bacterial cell, fungal cell, insect cell and vegetable cell.
9. the cell of claim 8, this cell is a kind of growing nonparasitically upon another plant in the bacterial cell of plant.
10. an Accessory Right requires 8 transformant regenerated transgenic plant.
11. an isolated nucleic acid molecule comprises the sequence that is selected from down group:
A) part or all of SEQ ID NO:1;
B) allelic variant of part or all of SEQ ID NO:1;
C) natural mutation of part or all of SEQ ID NO:1;
D) with the part or all of SEQ ID NO:1 or the sequence of its complement hybridization, the polypeptide of this sequence encoding any polypeptide with SEQ ID NO:1 coding basically is identical;
E) the part or all of sequence of coded polypeptide, polypeptide wherein contain the aminoacid sequence that is selected from down group: SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ IDNO:5, SEQ ID NO:6, SEQ ID NO:7 and SEQ ID NO:8.
12. an oligonucleotide that is about to 10-100 Nucleotide, this oligonucleotide specifically with the part making nucleic acid molecular hybridization of claim 11.
13. a recombinant DNA molecules, the nucleic acid molecule of the claim 11 that is connected with the carrier that is used for transformant with comprising operability.
14. recombinant DNA molecules cell transformed with claim 13.
15. the cell of claim 14, this cell is selected from bacterial cell, yeast cell and vegetable cell.
16. the cell of claim 15, this cell are a kind of growing nonparasitically upon another plant in the bacterial cell of plant.
17. the transgenic plant of the cell regeneration of an Accessory Right requirement 15.
18. polypeptide by the nucleic acid molecule encoding of claim 11.
19. specific antibody of the polypeptide immune to claim 18.
20. one kind by i(magnaporthe grisea) isolated nucleic acid molecule encoded protein, described nucleic acid can be given rice cultivar CO39 to containing the special nontoxicity of fungoid pathogenic of this nucleic acid.
21. the albumen of claim 20, this albumen is by the AVR1-CO39 genes encoding.
22. the albumen of claim 21, this albumen is by the ORF3 coding of AVR1-CO39.
23. the albumen of claim 20, this albumen contain aminoacid sequence SEQID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQID NO:5, SEQ ID NO:6, SEQ ID NO:7 and the SEQ ID NO:8 that is selected from down group.
24. an immunity is specifically at the antibody of the polypeptide of claim 20.
25. express the growing nonparasitically upon another plant in the transgenic bacteria of plant of part A VR1-CO39 gene for one kind, wherein the AVR1-CO39 gene is given rice cultivar CO39 the nontoxicity special to the microorganism of expressing this gene effectively.
26. growing nonparasitically upon another plant in the transgenic bacteria of plant of claim 24, the ORF3 of this bacterial expression SEQ IDNO:1 or function equate body.
Express the polypeptide processing plant that produces 27. a method that strengthens rice cultivar CO39 plant to the resistance scope of pathogenic micro-organism, this method comprise using by AVR1-CO39, used amount excites the special R expression of gene of CO39 in the plant effectively.
28. the method for claim 27, this method comprise with the solution treating plant that contains described polypeptide.
29. the method for claim 27, this method comprise that wherein the polypeptide of AVR1-CO39 genetic expression excites the special R expression of gene of CO39 in the plant effectively with the epiphytic bacterial treatment plant of expressing part A VR1-CO39 gene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7592598P | 1998-02-25 | 1998-02-25 | |
US60/075925 | 1998-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1308678A true CN1308678A (en) | 2001-08-15 |
Family
ID=22128797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99805473A Pending CN1308678A (en) | 1998-02-25 | 1999-02-25 | Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1056866A1 (en) |
JP (1) | JP2002504373A (en) |
KR (1) | KR20010041277A (en) |
CN (1) | CN1308678A (en) |
AU (1) | AU3310599A (en) |
CA (1) | CA2321950A1 (en) |
ID (1) | ID27274A (en) |
IL (1) | IL137881A0 (en) |
NO (1) | NO20004239L (en) |
WO (1) | WO1999043824A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002218017A1 (en) * | 2000-10-20 | 2002-05-06 | The United States Of America, As Represented By The Secretary Of Agriculture | Plant genes that confer resistance to strains of magnaporthe grisea having avr1 co39 cultivar specificity gene |
CN100398556C (en) * | 2006-03-16 | 2008-07-02 | 华南农业大学 | Rice blast fungus non-toxin gene Avr-pii and its application |
KR101112656B1 (en) * | 2009-04-07 | 2012-03-14 | 서울대학교산학협력단 | Novel pathogenicity gene in blast fungus to suppress basal defenses of host and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL9000773A (en) * | 1990-04-02 | 1991-11-01 | Rijkslandbouwhogeschool | PROCESS FOR PROTECTING PLANTS AGAINST PATHOGENS |
WO1995031564A2 (en) * | 1994-05-11 | 1995-11-23 | John Innes Centre Innovations Limited | Method of introducing pathogen resistance in plants |
US6100451A (en) * | 1995-05-18 | 2000-08-08 | Board Of Trustees Of The University Of Kentucky | Pathogen-inducible regulatory element |
ES2248810T3 (en) * | 1995-06-07 | 2006-03-16 | Cornell Res Foundation Inc | RESISTANCE INDUCED BY HYPERSENSIBLE RESPONSE IN PLANTS. |
CN1232502A (en) * | 1996-03-25 | 1999-10-20 | 佛罗里达大学 | Antibodies against avirulence/pathogenicity proteins of plant pathogens |
-
1999
- 1999-02-25 CA CA002321950A patent/CA2321950A1/en not_active Abandoned
- 1999-02-25 AU AU33105/99A patent/AU3310599A/en not_active Abandoned
- 1999-02-25 WO PCT/US1999/004047 patent/WO1999043824A1/en not_active Application Discontinuation
- 1999-02-25 CN CN99805473A patent/CN1308678A/en active Pending
- 1999-02-25 KR KR1020007009375A patent/KR20010041277A/en not_active Application Discontinuation
- 1999-02-25 EP EP99936094A patent/EP1056866A1/en not_active Withdrawn
- 1999-02-25 JP JP2000533563A patent/JP2002504373A/en active Pending
- 1999-02-25 IL IL13788199A patent/IL137881A0/en unknown
- 1999-02-25 ID IDW20001623A patent/ID27274A/en unknown
-
2000
- 2000-08-24 NO NO20004239A patent/NO20004239L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002504373A (en) | 2002-02-12 |
IL137881A0 (en) | 2001-10-31 |
ID27274A (en) | 2001-03-22 |
WO1999043824A1 (en) | 1999-09-02 |
NO20004239L (en) | 2000-10-19 |
NO20004239D0 (en) | 2000-08-24 |
KR20010041277A (en) | 2001-05-15 |
EP1056866A1 (en) | 2000-12-06 |
CA2321950A1 (en) | 1999-09-02 |
AU3310599A (en) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1849397A (en) | Insecticidal proteins secreted from bacillus thuringiensis and uses therefor | |
CN1231673A (en) | Polynucleotide and its use for modulating a defence response in plants | |
CN1114694C (en) | Procedures and materials for conferring disease resistance in plants | |
CN1333833A (en) | New method of identifying non-host plant disease resistance genes | |
CN1387572A (en) | Plant reglatory sequences for selective control of gene expression | |
CN1139454A (en) | Antimicrobial proteins | |
CN1134981A (en) | Expressive carrier with coded insect-killing protein fusion gene, and transfer gene plant | |
CN1143978A (en) | Antimicrobial proteins from aralia and impatiens | |
CN1316007A (en) | Polynucleotide sequences | |
CN1429269A (en) | Receptors for hypersensitive response elicitors and uses thereof | |
US9587248B2 (en) | Mayetiola destructor susceptibility gene one (Mds-1) and its application in pest management | |
CN110172465B (en) | Application of aspergillus flavus pathogenic gene wprA | |
CN1234831A (en) | Protein kinases and uses thereof | |
CN1308678A (en) | Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use | |
CN1765924A (en) | Plant adversity resistance related protein and encoding gene thereof and application | |
CN1379783A (en) | Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene | |
CN1280627A (en) | Proteinase inhibitor fusion proteins | |
CN1258317A (en) | Process for expression of genes of dengue viruses | |
CN1335855A (en) | Novel protein, gene encoding the same and method of utilization thereof | |
CN1219586A (en) | Two kinds of encoding insecticidal protein gene and bivalent fused expression carrier and their application | |
CN101062942A (en) | Aspergillus fumigatus original active oxygen lethality related protein and its coding gene | |
CN1084565A (en) | Have the active novel protein of Nitrile hydratase and this proteic gene of coding | |
CN1110559C (en) | Gene regulating aureobasidin sensitivity | |
US6794176B1 (en) | Cultivar specificity gene from the rice pathogen Magnaporthe grisea, and methods of use | |
CN1372436A (en) | Seedless fruit production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |